Mortality among Children Aged 1-59 Months in India: Evidence from a Systematic Review and Meta-Analysis (2009-2024)

印度1-59个月龄儿童死亡率:系统评价和荟萃分析的证据(2009-2024)

阅读:2

Abstract

BACKGROUND: Mortality among Indian children aged 1–59 months remains a concern, yet evidence arises from hospital and community settings that reflect different populations and metrics. A setting-specific synthesis is needed to clarify mortality trends, causes, and associated factors. METHODS: We reviewed observational studies (2009–2024) on deaths, causes, or risk factors among children aged 1–59 months. Two reviewers independently extracted data. Hospital and community studies were analyzed separately, using setting-specific mortality definitions. Random-effects GLM models pooled mortality and risk factors. Cause-of-death distributions and trends were synthesized only for hospital studies due to limited community data. FINDINGS: Sixty-seven studies were included: 50 hospital-based, 11 community-based, and six case-control. The pooled in-hospital mortality was 8.1%, with substantial heterogeneity (0.1%-65%); largely reflecting cohorts restricted to critically ill children. Pneumonia (38%), congenital anomalies (32%) and central nervous system infections (23%), accounted for most clinically ascertained deaths. Deaths declined over time (2.4%) particularly during the pre-COVID period; while post-COVID trends were imprecise; a regional decline (3%) was detected only in northern India. Community mortality was highly heterogeneous, with a pooled estimate of 3.3% and data were insufficient for trend analysis. Female sex and lack of immunization were significantly associated with in hospital mortality, while no significant risk factors were identified in community analyses. CONCLUSION: India achieved meaningful reductions in child mortality, although recent trends remain uncertain following the COVID-19 period. Persistent heterogeneity across settings and sex differences in hospital-based mortality underscore the need for strengthened community surveillance and standardized reporting to sustain and accelerate national gains. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44197-026-00522-1.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。